BDBM161808 US9682976, 249

SMILES Cc1nnnn1-c1cc(Nc2ncc(F)c(N[C@@H]3C[C@@H]4CCCN4C(C)(C)C3)n2)c(F)cc1OC1COC1

InChI Key InChIKey=RWGKCGWOYIOHLQ-CVEARBPZSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 161808   

TargetInterleukin-2(Homo sapiens (Human))
Rigel Pharmaceuticals

US Patent
LigandPNGBDBM161808(US9682976, 249)
Affinity DataEC50: <100nMAssay Description:Primary T cell stimulation and IL2 ELISA: Human primary T cells (100,000 cells per well) were pre-incubated with or without test compound in Yssel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent